Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis

Nature Medicine

Volumn 21, Issue 9, 2015, Pages 998-1009

  Lovisa, Sara ^a   LeBleu, Valerie S ^a   Tampe, Björn ^b   Sugimoto, Hikaru ^a   Vadnagara, Komal ^a   Carstens, Julienne L ^a   Wu, Chia Chin ^a   Hagos, Yohannes ^b   Burckhardt, Birgitta C ^b   Pentcheva Hoang, Tsvetelina ^a   Nischal, Hersharan ^a   Allison, James P ^a   Zeisberg, Michael ^b   Kalluri, Raghu ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SOLVENT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNAI1; TRANSCRIPTION FACTOR TWIST1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; AQUAPORIN 1; ORGANIC ANION TRANSPORTER 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL DEDIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; EXPERIMENTAL RENAL FIBROSIS; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY PARENCHYMA; MESENCHYME CELL; MOUSE; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; SOLUTE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; CELL CYCLE CHECKPOINT; FIBROSIS; GENETICS; KIDNEY; PATHOLOGY;

ANIMALS; AQUAPORIN 1; CELL CYCLE CHECKPOINTS; CELLS, CULTURED; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; G2 PHASE; HUMANS; KIDNEY; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; ORGANIC ANION TRANSPORT PROTEIN 1;

EID: 84941007847     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3902     Document Type: Article

References (55)

1. Zeisberg, M. & Kalluri, R. Cellular mechanisms of tissue fibrosis. Common and organ-specific mechanisms associated with tissue fibrosis. Am. J. Physiol. Cell Physiol. 304, C216-C225 (2013).
2. Grams, M.E. et al. Lifetime incidence of CKD stages 3-5 in the United States. Am. J. Kidney Dis. 62, 245-252 (2013).
3. Sugimoto, H. et al. Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat. Med. 18, 396-404 (2012).
4. LeBleu, V.S. et al. Origin and function of myofibroblasts in kidney fibrosis. Nat. Med. 19, 1047-1053 (2013).
5. Bechtel, W. et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat. Med. 16, 544-550 (2010).
6. Iwano, M. et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin. Invest. 110, 341-350 (2002).
7. Zeisberg, M. & Kalluri, R. Fibroblasts emerge via epithelial-mesenchymal transition in chronic kidney fibrosis. Front. Biosci. 13, 6991-6998 (2008).
8. Zeisberg, E.M. et al. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J. Am. Soc. Nephrol. 19, 2282-2287 (2008).
9. Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178-196 (2014).
10. Lee, K. & Nelson, C.M. New insights into the regulation of epithelial-mesenchymal transition and tissue fibrosis. Int. Rev. Cell Mol. Biol. 294, 171-221 (2012).
11. Zeisberg, M. et al. Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am. J. Pathol. 159, 1313-1321 (2001).
12. Zeisberg, M. et al. Renal fibrosis. Extracellular matrix microenvironment regulates migratory behavior of activated tubular epithelial cells. Am. J. Pathol. 160, 2001-2008 (2002).
13. Zeisberg, M. & Kalluri, R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J. Mol. Med. (Berl) 82, 175-181 (2004).
14. Burns, W.C., Kantharidis, P. & Thomas, M.C. The role of tubular epithelial-mesenchymal transition in progressive kidney disease. Cells Tissues Organs 185, 222-231 (2007).
15. Teng, Y., Zeisberg, M. & Kalluri, R. Transcriptional regulation of epithelial-mesenchymal transition. J. Clin. Invest. 117, 304-306 (2007).
16. Kida, Y. et al. Twist relates to tubular epithelial-mesenchymal transition and interstitial fibrogenesis in the obstructed kidney. J. Histochem. Cytochem. 55, 661-673 (2007).
17. Strutz, F. et al. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int. 61, 1714-1728 (2002).
18. Kalluri, R. & Weinberg, R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420-1428 (2009).
19. Hertig, A. et al. Early epithelial phenotypic changes predict graft fibrosis. J. Am. Soc. Nephrol. 19, 1584-1591 (2008).
20. Boutet, A. et al. Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J. 25, 5603-5613 (2006).
21. Rastaldi, M.P. Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis. J. Nephrol. 19, 407-412 (2006).
22. Kriz, W., Kaissling, B. & Le Hir, M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J. Clin. Invest. 121, 468-474 (2011).
23. Zeisberg, M. & Duffield, J.S. Resolved: EMT produces fibroblasts in the kidney. J. Am. Soc. Nephrol. 21, 1247-1253 (2010).
24. Liu, Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J. Am. Soc. Nephrol. 21, 212-222 (2010).
25. Yang, L. et al. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat. Med. 16, 535-543 (2010).
26. Canaud, G. & Bonventre, J.V. Cell cycle arrest and the evolution of chronic kidney disease from acute kidney injury. Nephrol. Dial. Transplant. 30, 575-583 (2015).
27. Kang, H.M. et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat. Med. 21, 37-46 (2015).
28. Rajasekaran, S.A. et al. Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis. Mol. Cancer Ther. 9, 1515-1524 (2010).
29. Ito, S. et al. Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease. J. Leukoc. Biol. 93, 837-845 (2013).
30. Lui, T. et al. Changes in expression of renal Oat1, Oat3 and Mrp2 in cisplatin-induced acute renal failure after treatment of JBP485 in rats. Toxicol. Appl. Pharmacol. 264, 423-430 (2012).
31. Hills, C.E., Willars, G.B. & Brunskill, N.J. Proinsulin C-peptide antagonizes the profibrotic effects of TGF-β1 via up-regulation of retinoic acid and HGF-related signaling pathways. Mol. Endocrinol. 24, 822-831 (2010).
32. Köttgen, A. et al. New loci associated with kidney function and chronic kidney disease. Nat. Genet. 42, 376-384 (2010).
33. Martini, S. et al. Integrative biology identifies shared transcriptional networks in CKD. J. Am. Soc. Nephrol. 25, 2559-2572 (2014).
34. Reich, H.N. et al. A molecular signature of proteinuria in glomerulonephritis. PLoS ONE 5, e13451 (2010).
35. Schmid, H. et al. Modular activation of nuclear factor-B transcriptional programs in human diabetic nephropathy. Diabetes 55, 2993-3003 (2006).
36. Neusser, M.A. et al. Human nephrosclerosis triggers a hypoxia-related glomerulopathy. Am. J. Pathol. 176, 594-607 (2010).
37. Hodgin, J.B. et al. A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue. Am. J. Pathol. 177, 1674-1686 (2010).
38. Doherty, J.R. & Cleveland, J.L. Targeting lactate metabolism for cancer therapeutics. J. Clin. Invest. 123, 3685-3692 (2013).
39. Stern, R. et al. Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited. Exp. Cell Res. 276, 24-31 (2002).
40. Maeda, T. et al. Mechanism of the regulation of organic cation/carnitine transporter 1 (SLC22A4) by rheumatoid arthritis-associated transcriptional factor RUNX1 and inflammatory cytokines. Drug Metab. Dispos. 35, 394-401 (2007).
41. Toyohara, T. et al. SLCO4C1 transporter eliminates uremic toxins and attenuates hypertension and renal inflammation. J. Am. Soc. Nephrol. 20, 2546-2555 (2009).
42. Wynn, T.A. Cellular and molecular mechanisms of fibrosis. J. Pathol. 214, 199-210 (2008).
43. Witzgall, R. et al. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J. Clin. Invest. 93, 2175-2188 (1994).
44. Duffield, J.S. et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J. Clin. Invest. 115, 1743-1755 (2005).
45. Wu, C.F. et al. Transforming growth factor beta-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis. Am. J. Pathol. 182, 118-131 (2013).
46. Vega, S. et al. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev. 18, 1131-1143 (2004).
47. Megyesi, J. et al. The lack of a functional p21(WAF1/CIP1) gene ameliorates progression to chronic renal failure. Proc. Natl. Acad. Sci. USA 96, 10830-10835 (1999).
48. Cooke, V.G. et al. Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell 21, 66-81 (2012).
49. Wynn, T.A. Fibrosis under arrest. Nat. Med. 16, 523-525 (2010).
50. Rowe, R.G. et al. Hepatocyte-derived Snail1 propagates liver fibrosis progression. Mol. Cell. Biol. 31, 2392-2403 (2011).
51. LeBleu, V.S. et al. Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat. Med. 19, 227-231 (2013).
52. Smyth, G.K. Limma: linear models for microarray data. In Bioinformatics and Computational Biology Solutions using R and Bioconductor. (Springer, 2005).
53. Haverty, T.P. et al. Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J. Cell Biol. 107, 1359-1368 (1988).
54. Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939 (2004).
55. Olive, P.L. & Banath, J.P. The comet assay: a method to measure DNA damage in individual cells. Nat. Protoc. 1, 23-29 (2006).